[
  {
    "title": "一品红：AR882取得全球Ⅱb期临床试验结果 表现出良好耐受性",
    "href": "http://stock.jrj.com.cn/2023/01/06142837263992.shtml",
    "datetime": "2023-01-06 14:28:06",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：AR882取得全球Ⅱb期临床试验结果 有效性和安全性良好",
    "href": "http://stock.jrj.com.cn/2023/01/06132337263825.shtml",
    "datetime": "2023-01-06 13:23:31",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：氨甲环酸注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2023/01/05191037262192.shtml",
    "datetime": "2023-01-05 19:10:02",
    "code": "300723"
  },
  {
    "title": "一品红：全资子公司获得氨甲环酸注射液注册证书",
    "href": "http://stock.jrj.com.cn/2023/01/05185437262143.shtml",
    "datetime": "2023-01-05 18:54:18",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：一品红大药房已完成工商注册登记手续并取得营业执照",
    "href": "http://stock.jrj.com.cn/2022/12/26161437238126.shtml",
    "datetime": "2022-12-26 16:14:57",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：AR882胶囊获批进行痛风适应症临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/21155637228359.shtml",
    "datetime": "2022-12-21 15:56:13",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：左氧氟沙星片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/12/07165637195289.shtml",
    "datetime": "2022-12-07 16:56:00",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：不提前赎回“一品转债”",
    "href": "http://stock.jrj.com.cn/2022/11/29193237175494.shtml",
    "datetime": "2022-11-29 19:32:55",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：“一品转债”可能满足赎回条件",
    "href": "http://stock.jrj.com.cn/2022/11/21192737155288.shtml",
    "datetime": "2022-11-21 19:27:24",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：董秘张明渊11月7日增持3.23万股",
    "href": "http://stock.jrj.com.cn/2022/11/08115737119767.shtml",
    "datetime": "2022-11-08 11:57:10",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟推528.1万股的2022年股票期权与限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/11/02194437107695.shtml",
    "datetime": "2022-11-02 19:44:25",
    "code": "300723"
  },
  {
    "title": "一品红2022年前三季度净利2.66亿同比下滑7.75% 慢病药营业收入下降",
    "href": "http://stock.jrj.com.cn/2022/10/19195037068023.shtml",
    "datetime": "2022-10-19 19:50:11",
    "code": "300723"
  },
  {
    "title": "一品红：前三季度净利润2.66亿元 同比下降7.75%",
    "href": "http://stock.jrj.com.cn/2022/10/19172137067353.shtml",
    "datetime": "2022-10-19 17:21:41",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)三季度净利润1.11亿元 同比下降34.62%",
    "href": "http://stock.jrj.com.cn/2022/10/19171237067347.shtml",
    "datetime": "2022-10-19 17:12:34",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司盐酸依匹斯汀片获批",
    "href": "http://stock.jrj.com.cn/2022/10/17114937059790.shtml",
    "datetime": "2022-10-17 11:49:10",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司盐酸依匹斯汀颗粒获批",
    "href": "http://stock.jrj.com.cn/2022/10/17114737059791.shtml",
    "datetime": "2022-10-17 11:47:45",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人解质1084.57万股",
    "href": "http://stock.jrj.com.cn/2022/09/19161537004896.shtml",
    "datetime": "2022-09-19 16:15:42",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：盐酸氨溴索滴剂新增规格(20ml:300mg)获批上市",
    "href": "http://stock.jrj.com.cn/2022/09/19114937004169.shtml",
    "datetime": "2022-09-19 11:49:01",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：羧甲司坦口服溶液上市许可持有人变更为一品红制药",
    "href": "http://stock.jrj.com.cn/2022/08/16162136904511.shtml",
    "datetime": "2022-08-16 16:21:52",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人之一吴美容质押1699.104万股",
    "href": "http://stock.jrj.com.cn/2022/08/12160736895171.shtml",
    "datetime": "2022-08-12 16:07:31",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人之一吴美容解质781万股",
    "href": "http://stock.jrj.com.cn/2022/08/10154636886734.shtml",
    "datetime": "2022-08-10 15:46:43",
    "code": "300723"
  },
  {
    "title": "一品红半年报：盈利能力突出 未来业绩可期",
    "href": "http://stock.jrj.com.cn/2022/07/31104536856425.shtml",
    "datetime": "2022-07-31 10:45:41",
    "code": "300723"
  },
  {
    "title": "一品红2022年上半年净利1.55亿同比增长31.06% 医药制造产品收入增长",
    "href": "http://stock.jrj.com.cn/2022/07/28183236851249.shtml",
    "datetime": "2022-07-28 18:32:33",
    "code": "300723"
  },
  {
    "title": "一品红：上半年净利润1.55亿元 同比增长31.06%",
    "href": "http://stock.jrj.com.cn/2022/07/28165636850694.shtml",
    "datetime": "2022-07-28 16:56:11",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟使用不超5亿元暂时闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/07/28165036850729.shtml",
    "datetime": "2022-07-28 16:50:31",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)半年度净利润1.55亿元、同比增长31.06%",
    "href": "http://stock.jrj.com.cn/2022/07/28163736850593.shtml",
    "datetime": "2022-07-28 16:37:26",
    "code": "300723"
  },
  {
    "title": "第七批国家药品集采产生拟中选结果，立方制药、一品红、翰宇药业等多家公司公告多款产品拟中标",
    "href": "http://stock.jrj.com.cn/2022/07/12201636804628.shtml",
    "datetime": "2022-07-12 20:16:24",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司获得磷酸奥司他韦胶囊注册证书",
    "href": "http://stock.jrj.com.cn/2022/07/05155136783576.shtml",
    "datetime": "2022-07-05 15:51:43",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司羧甲司坦口服溶液获批",
    "href": "http://stock.jrj.com.cn/2022/06/27175736761800.shtml",
    "datetime": "2022-06-27 17:57:17",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：61.29万股限制性股票6月14日解锁上市",
    "href": "http://stock.jrj.com.cn/2022/06/09171936716254.shtml",
    "datetime": "2022-06-09 17:19:26",
    "code": "300723"
  },
  {
    "title": "一品红副总经理谢小华辞职 2021年薪酬为102.2万",
    "href": "http://stock.jrj.com.cn/2022/06/07183136709881.shtml",
    "datetime": "2022-06-07 18:31:11",
    "code": "300723"
  },
  {
    "title": "一品红：谢小华因个人原因申请辞去公司副总经理、董秘职务",
    "href": "http://stock.jrj.com.cn/2022/06/07173136709693.shtml",
    "datetime": "2022-06-07 17:31:20",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：61.29万股限制性股票可解锁",
    "href": "http://stock.jrj.com.cn/2022/06/07163536709312.shtml",
    "datetime": "2022-06-07 16:35:20",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人之一吴美容解押756.1036万股",
    "href": "http://stock.jrj.com.cn/2022/05/30155636689581.shtml",
    "datetime": "2022-05-30 15:56:47",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人吴美容解质943万股及再质押781万股",
    "href": "http://stock.jrj.com.cn/2022/05/25181736678329.shtml",
    "datetime": "2022-05-25 18:17:13",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：2021年度权益分派10派2元 股权登记日为5月24日",
    "href": "http://stock.jrj.com.cn/2022/05/17200536656382.shtml",
    "datetime": "2022-05-17 20:05:55",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：与晟德大药厂签署终止合作协议、品晟医药将成为公司间接出资的全资子公司",
    "href": "http://stock.jrj.com.cn/2022/05/12183736643725.shtml",
    "datetime": "2022-05-12 18:37:36",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司盐酸文拉法辛缓释胶囊获批",
    "href": "http://stock.jrj.com.cn/2022/05/09115236604601.shtml",
    "datetime": "2022-05-09 11:52:33",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：截至4月底已累计回购1.76%股份",
    "href": "http://stock.jrj.com.cn/2022/05/05161436569643.shtml",
    "datetime": "2022-05-05 16:14:21",
    "code": "300723"
  },
  {
    "title": "一品红发布2021年报：营收净利显著增长 布局热门赛道未来发展可期",
    "href": "http://stock.jrj.com.cn/2022/04/23101336435286.shtml",
    "datetime": "2022-04-23 10:13:51",
    "code": "300723"
  },
  {
    "title": "一品红2022年第一季度净利7979.31万同比增长17.27% 医药制造业务收入同比快速增长",
    "href": "http://stock.jrj.com.cn/2022/04/21191336421004.shtml",
    "datetime": "2022-04-21 19:13:09",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：一季度净利增17.27%至7979.31万元",
    "href": "http://stock.jrj.com.cn/2022/04/20193936412017.shtml",
    "datetime": "2022-04-20 19:39:54",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：2021年净利增36.04%至3.07亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2022/04/20193736412021.shtml",
    "datetime": "2022-04-20 19:37:51",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟通过瑞奥生物对华南疫苗增资4988.07万元",
    "href": "http://stock.jrj.com.cn/2022/03/17155134839191.shtml",
    "datetime": "2022-03-17 15:51:55",
    "code": "300723"
  },
  {
    "title": "一品红：一品红制药帕瑞昔布钠原料药通过CDE技术审评",
    "href": "http://stock.jrj.com.cn/2022/03/03144334515818.shtml",
    "datetime": "2022-03-03 14:43:11",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司帕瑞昔布钠原料药通过CDE技术审评",
    "href": "http://stock.jrj.com.cn/2022/03/03115234515416.shtml",
    "datetime": "2022-03-03 11:52:39",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)截止2月底已累计回购1.42%的股份",
    "href": "http://stock.jrj.com.cn/2022/03/01160434508136.shtml",
    "datetime": "2022-03-01 16:04:08",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司硝苯地平控释片获批上市",
    "href": "http://stock.jrj.com.cn/2022/02/09155234313403.shtml",
    "datetime": "2022-02-09 15:52:10",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：截至1月底累计耗资1.2亿元回购1.42%股份",
    "href": "http://stock.jrj.com.cn/2022/02/08115834305156.shtml",
    "datetime": "2022-02-08 11:58:14",
    "code": "300723"
  },
  {
    "title": "一品红业绩预增30%-60% 研发投入增五成 儿童药市场潜力大",
    "href": "http://stock.jrj.com.cn/2022/01/12075234148793.shtml",
    "datetime": "2022-01-12 07:52:00",
    "code": "300723"
  },
  {
    "title": "一品红2021年预计净利2.93亿-3.61亿增长30%-60% 自研产品收入快速增长",
    "href": "http://stock.jrj.com.cn/2022/01/10190834142416.shtml",
    "datetime": "2022-01-10 19:08:05",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：2021年度净利预增30%-60%",
    "href": "http://stock.jrj.com.cn/2022/01/10160434141349.shtml",
    "datetime": "2022-01-10 16:04:41",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：缬沙坦氨氯地平片(I)获批上市",
    "href": "http://stock.jrj.com.cn/2022/01/06183034130451.shtml",
    "datetime": "2022-01-06 18:30:20",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司拟受让非诺贝特胆碱缓释胶囊和原料药在国内的产品所有权",
    "href": "http://stock.jrj.com.cn/2021/12/20214834036839.shtml",
    "datetime": "2021-12-20 21:48:53",
    "code": "300723"
  },
  {
    "title": "一品红选举李捍雄为董事长 第三季度公司净利1.7亿",
    "href": "http://stock.jrj.com.cn/2021/12/07201033981388.shtml",
    "datetime": "2021-12-07 20:10:58",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人李捍雄、吴美容合计质押展期3355.1万股",
    "href": "http://stock.jrj.com.cn/2021/12/02160733955529.shtml",
    "datetime": "2021-12-02 16:07:19",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：截至11月底已累计回购1.36%股份",
    "href": "http://stock.jrj.com.cn/2021/12/01164133950074.shtml",
    "datetime": "2021-12-01 16:41:17",
    "code": "300723"
  },
  {
    "title": "一品红股东广州福泽减持540万股 套现约1.67亿 第三季度公司净利1.7亿",
    "href": "http://stock.jrj.com.cn/2021/11/26203233925016.shtml",
    "datetime": "2021-11-26 20:32:11",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：广州福泽已减持540万股 减持计划提前实施完毕",
    "href": "http://stock.jrj.com.cn/2021/11/26181533924414.shtml",
    "datetime": "2021-11-26 18:15:15",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：广州福泽近期大宗交易减持345万股",
    "href": "http://stock.jrj.com.cn/2021/11/26115533922956.shtml",
    "datetime": "2021-11-26 11:55:39",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：广州福泽减持量过半 累计减持1.2%股份",
    "href": "http://stock.jrj.com.cn/2021/11/25165133919230.shtml",
    "datetime": "2021-11-25 16:51:06",
    "code": "300723"
  },
  {
    "title": "一品红：子公司获得多索茶碱注射液注册证书 将进一步丰富公司产品管线和品类",
    "href": "http://stock.jrj.com.cn/2021/11/22141733903615.shtml",
    "datetime": "2021-11-22 14:17:27",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：全资子公司多索茶碱注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/11/22114633903030.shtml",
    "datetime": "2021-11-22 11:46:47",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：监事张迎迎完成减持900股",
    "href": "http://stock.jrj.com.cn/2021/11/09162533827832.shtml",
    "datetime": "2021-11-09 16:25:01",
    "code": "300723"
  },
  {
    "title": "一品红喜获药品注册证书 营销驱动前三季销售费9.5亿占营收58%",
    "href": "http://stock.jrj.com.cn/2021/11/09130433827228.shtml",
    "datetime": "2021-11-09 13:04:02",
    "code": "300723"
  },
  {
    "title": "一品红新药获注册 研发费用增长超五成 主营业务潜力巨大",
    "href": "http://stock.jrj.com.cn/2021/11/09093133826841.shtml",
    "datetime": "2021-11-09 09:31:00",
    "code": "300723"
  },
  {
    "title": "一品红：子公司获得注射用兰索拉唑注册证书 有助于增强公司在慢病领域竞争力",
    "href": "http://stock.jrj.com.cn/2021/11/08144133823072.shtml",
    "datetime": "2021-11-08 14:41:27",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：全资子公司注射用兰索拉唑获批上市",
    "href": "http://stock.jrj.com.cn/2021/11/08114933822608.shtml",
    "datetime": "2021-11-08 11:49:14",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)截止10月底已累计回购1.36%的股份",
    "href": "http://stock.jrj.com.cn/2021/11/01165133798254.shtml",
    "datetime": "2021-11-01 16:51:15",
    "code": "300723"
  },
  {
    "title": "A股异动 | 一品红(300723.SZ)涨超4% 三季度净利同比增长46.66%",
    "href": "http://stock.jrj.com.cn/2021/10/22094433731543.shtml",
    "datetime": "2021-10-22 09:44:58",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)第三季度净利润1.70亿元 同比增长46.66%",
    "href": "http://stock.jrj.com.cn/2021/10/21160833727248.shtml",
    "datetime": "2021-10-21 16:08:01",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：AR882胶囊在中国获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/20155333721771.shtml",
    "datetime": "2021-10-20 15:53:29",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)截止9月底已累计回购1.36%的股份",
    "href": "http://stock.jrj.com.cn/2021/10/10145433663582.shtml",
    "datetime": "2021-10-10 14:54:22",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：累计获得政府补助合计8521.23万元",
    "href": "http://stock.jrj.com.cn/2021/09/29220433538698.shtml",
    "datetime": "2021-09-29 22:04:59",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司获得盐酸溴己新注射液注册证书",
    "href": "http://stock.jrj.com.cn/2021/09/15161833439857.shtml",
    "datetime": "2021-09-15 16:18:54",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：苯甲酸氨氯地平干混悬剂获批临床",
    "href": "http://stock.jrj.com.cn/2021/09/13161133428530.shtml",
    "datetime": "2021-09-13 16:11:12",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：李捍东、吴春江提前终止减持计划 已合计减持2.01%股份",
    "href": "http://stock.jrj.com.cn/2021/09/03115033379023.shtml",
    "datetime": "2021-09-03 11:50:26",
    "code": "300723"
  },
  {
    "title": "上半年业绩与股价“双飞” 一品红实控人家族减持近600万股",
    "href": "http://stock.jrj.com.cn/2021/09/02082233372812.shtml",
    "datetime": "2021-09-02 08:22:00",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)截止8月底已累计回购1.36%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/01162733367988.shtml",
    "datetime": "2021-09-01 16:27:16",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：李捍东及吴春江已合计减持579.4229万股、广州福泽尚未减持",
    "href": "http://stock.jrj.com.cn/2021/08/31214333363742.shtml",
    "datetime": "2021-08-31 21:43:50",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：克林霉素磷酸酯注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/08/30194833354687.shtml",
    "datetime": "2021-08-30 19:48:45",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：股东李捍东质押430万股",
    "href": "http://stock.jrj.com.cn/2021/08/10222333233971.shtml",
    "datetime": "2021-08-10 22:23:48",
    "code": "300723"
  },
  {
    "title": "一品红股东李捍东质押430万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2021/08/10203333233517.shtml",
    "datetime": "2021-08-10 20:33:26",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟对品晟医药增资并引进二型糖尿病治疗口服创新药等",
    "href": "http://stock.jrj.com.cn/2021/08/06202633214403.shtml",
    "datetime": "2021-08-06 20:26:18",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)截止7月底已累计回购1.06%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/02213333190850.shtml",
    "datetime": "2021-08-02 21:33:13",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：“一品转债”自8月3日起开始转股",
    "href": "http://stock.jrj.com.cn/2021/07/30175233176185.shtml",
    "datetime": "2021-07-30 17:52:32",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：控股子公司持有华南疫苗52.7077%的股权",
    "href": "http://stock.jrj.com.cn/2021/07/29214933171662.shtml",
    "datetime": "2021-07-29 21:49:18",
    "code": "300723"
  },
  {
    "title": "一品红2021年上半年净利1.18亿增长46.61% 新自研产品投放市场",
    "href": "http://stock.jrj.com.cn/2021/07/29194233170840.shtml",
    "datetime": "2021-07-29 19:42:56",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)半年度净利润升46.61%至1.18亿元",
    "href": "http://stock.jrj.com.cn/2021/07/29172833170176.shtml",
    "datetime": "2021-07-29 17:28:35",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟使用不超3亿元暂时闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/07/27214633159957.shtml",
    "datetime": "2021-07-27 21:46:17",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司拟以2500万美元参与Arthrosi C2轮融资并与其就两项创新药进行合作",
    "href": "http://stock.jrj.com.cn/2021/07/27182833159129.shtml",
    "datetime": "2021-07-27 18:28:22",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)截止6月底已累计回购1.06%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/02173033034229.shtml",
    "datetime": "2021-07-02 17:30:52",
    "code": "300723"
  },
  {
    "title": "一品红子公司瑞奥生物以增资入股和转让老股方式合计1.35亿元投资华南疫苗 持股52.71%",
    "href": "http://stock.jrj.com.cn/2021/07/01195433028843.shtml",
    "datetime": "2021-07-01 19:54:22",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：吴春江已通过大宗交易减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/06/24170232990208.shtml",
    "datetime": "2021-06-24 17:02:30",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：董事李捍东减持股份比例达到1%",
    "href": "http://stock.jrj.com.cn/2021/06/22182432977298.shtml",
    "datetime": "2021-06-22 18:24:39",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：吴春江拟减持不超577.31万股",
    "href": "http://stock.jrj.com.cn/2021/06/16181332941576.shtml",
    "datetime": "2021-06-16 18:13:49",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：董事李捍东已减持168.394万股",
    "href": "http://stock.jrj.com.cn/2021/06/10191132906527.shtml",
    "datetime": "2021-06-10 19:11:44",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：已累计回购1.06%的股份",
    "href": "http://stock.jrj.com.cn/2021/06/09161032899950.shtml",
    "datetime": "2021-06-09 16:10:01",
    "code": "300723"
  },
  {
    "title": "一品红美国子公司拟以自有资金500万美元对Lyndra进行增资",
    "href": "http://stock.jrj.com.cn/2021/06/07213832889032.shtml",
    "datetime": "2021-06-07 21:38:38",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟以500万美元参股超长效缓释药制剂创新药企业Lyndra",
    "href": "http://stock.jrj.com.cn/2021/06/07191032888270.shtml",
    "datetime": "2021-06-07 19:10:23",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：一品红药业(润霖)研发中心建设项目结项",
    "href": "http://stock.jrj.com.cn/2021/06/02190232864849.shtml",
    "datetime": "2021-06-02 19:02:26",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：李捍东拟减持不超1.05%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/27203432831804.shtml",
    "datetime": "2021-05-27 20:34:51",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：注射用奥美拉唑钠20mg、40mg双规格通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/26154732823209.shtml",
    "datetime": "2021-05-26 15:47:20",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：盐酸左西替利嗪口服滴剂获批上市",
    "href": "http://stock.jrj.com.cn/2021/05/25160732816674.shtml",
    "datetime": "2021-05-25 16:07:44",
    "code": "300723"
  },
  {
    "title": "一品红：公司股东股份解除质押",
    "href": "http://stock.jrj.com.cn/2021/05/24155632811041.shtml",
    "datetime": "2021-05-24 15:56:06",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：董事李捍东解除质押675万股",
    "href": "http://stock.jrj.com.cn/2021/05/24154032810557.shtml",
    "datetime": "2021-05-24 15:40:27",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：5月19日首次回购54.30万股",
    "href": "http://stock.jrj.com.cn/2021/05/19155932781899.shtml",
    "datetime": "2021-05-19 15:59:48",
    "code": "300723"
  },
  {
    "title": "一品红子公司瑞奥生物以自有资金3500万对分迪药业进行增资",
    "href": "http://stock.jrj.com.cn/2021/05/12205632744028.shtml",
    "datetime": "2021-05-12 20:56:25",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：授予98名激励对象262.26万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/05/12172432742783.shtml",
    "datetime": "2021-05-12 17:24:25",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：以3500万元对创新药研发公司分迪药业进行增资",
    "href": "http://stock.jrj.com.cn/2021/05/12172332742772.shtml",
    "datetime": "2021-05-12 17:23:31",
    "code": "300723"
  },
  {
    "title": "A股异动 | 一品红(300723.SZ)跌超4% 股东拟减持不超过5.24%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/11104632734499.shtml",
    "datetime": "2021-05-11 10:46:25",
    "code": "300723"
  },
  {
    "title": "一品红(300723)：拟回购1亿元至2亿元股份 用于员工持股计划或股权激励",
    "href": "http://stock.jrj.com.cn/2021/05/10210432731995.shtml",
    "datetime": "2021-05-10 21:04:45",
    "code": "300723"
  },
  {
    "title": "一品红将花不超2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/05/10204832731736.shtml",
    "datetime": "2021-05-10 20:48:33",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟以1亿-2亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/05/10200932731533.shtml",
    "datetime": "2021-05-10 20:09:30",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：广州福泽、李捍东及吴春江拟合计减持不超1502.4479万股",
    "href": "http://stock.jrj.com.cn/2021/05/10200732731526.shtml",
    "datetime": "2021-05-10 20:07:28",
    "code": "300723"
  },
  {
    "title": "一品红：公司产品聚焦于儿童药和慢病药领域 主要从事处方药研发、生产和销售",
    "href": "http://stock.jrj.com.cn/2021/04/19105332400279.shtml",
    "datetime": "2021-04-19 10:53:25",
    "code": "300723"
  },
  {
    "title": "一品红2021年第一季度净利增长57.31% 自研产品收入快速增长",
    "href": "http://stock.jrj.com.cn/2021/04/12210632359693.shtml",
    "datetime": "2021-04-12 21:06:50",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)一季度净利升57.31%至6804.07万元",
    "href": "http://stock.jrj.com.cn/2021/04/12171832358342.shtml",
    "datetime": "2021-04-12 17:18:28",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟与广发信德、广发乾和共同合作设立广发信德瑞腾创投产业基金",
    "href": "http://stock.jrj.com.cn/2021/04/01163632263498.shtml",
    "datetime": "2021-04-01 16:36:46",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：拟向相关银行申请综合授信额度20亿元",
    "href": "http://stock.jrj.com.cn/2021/03/30133832247492.shtml",
    "datetime": "2021-03-30 13:38:39",
    "code": "300723"
  },
  {
    "title": "一品红2020年净利增长57.02% 董事长李捍雄薪酬65.36万",
    "href": "http://stock.jrj.com.cn/2021/03/30094532246321.shtml",
    "datetime": "2021-03-30 09:45:59",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)2020年度净利润升57.02%至2.26亿元 拟10转8派2.5元",
    "href": "http://stock.jrj.com.cn/2021/03/29214332243454.shtml",
    "datetime": "2021-03-29 21:43:33",
    "code": "300723"
  },
  {
    "title": "一品红：盐酸氨溴索滴剂获药品注册证书 将进一步丰富公司儿童药产品管线",
    "href": "http://stock.jrj.com.cn/2021/03/15150832136633.shtml",
    "datetime": "2021-03-15 15:08:33",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司盐酸氨溴索滴剂获药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/03/15120332135335.shtml",
    "datetime": "2021-03-15 12:03:43",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：注射用阿昔洛韦取得药品补充申请批准",
    "href": "http://stock.jrj.com.cn/2021/03/02173532058296.shtml",
    "datetime": "2021-03-02 17:35:42",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：陕国投●弘盛26号证券投资集合资金信托计划买入一品转债150万张",
    "href": "http://stock.jrj.com.cn/2021/02/25165732026087.shtml",
    "datetime": "2021-02-25 16:57:54",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)拟推155.65万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/02/23172332013091.shtml",
    "datetime": "2021-02-23 17:23:07",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：4.8亿元可转债将于2月23日起在深交所挂牌交易",
    "href": "http://stock.jrj.com.cn/2021/02/18164131987002.shtml",
    "datetime": "2021-02-18 16:41:28",
    "code": "300723"
  },
  {
    "title": "一品红：已建设儿童药高端制剂技术平台、慢病药缓控释剂技术平台等",
    "href": "http://stock.jrj.com.cn/2021/01/27171231790893.shtml",
    "datetime": "2021-01-27 17:12:35",
    "code": "300723"
  },
  {
    "title": "一品红：公司可根据项目进度的实际情况通过自筹资金先行投入 并在募集资金到位后予以置换",
    "href": "http://stock.jrj.com.cn/2021/01/27144931789397.shtml",
    "datetime": "2021-01-27 14:49:45",
    "code": "300723"
  },
  {
    "title": "一品红：本次募集资金投资项目的建设计划能否按时完成、项目的实施过程和实施效果等存在着不确定性",
    "href": "http://stock.jrj.com.cn/2021/01/27144531789303.shtml",
    "datetime": "2021-01-27 14:45:40",
    "code": "300723"
  },
  {
    "title": "一品红：公司经营业绩受集中采购政策影响较小",
    "href": "http://stock.jrj.com.cn/2021/01/27144531789302.shtml",
    "datetime": "2021-01-27 14:45:21",
    "code": "300723"
  },
  {
    "title": "一品红：公司有1家参股公司",
    "href": "http://stock.jrj.com.cn/2021/01/27144531789304.shtml",
    "datetime": "2021-01-27 14:45:07",
    "code": "300723"
  },
  {
    "title": "一品红2020年预计净利2.16亿-2.3亿增长50%-60% 自研产品收入持续增长",
    "href": "http://stock.jrj.com.cn/2021/01/26205131780308.shtml",
    "datetime": "2021-01-26 20:51:40",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：盐酸氨溴索注射液获药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/01/08160831655209.shtml",
    "datetime": "2021-01-08 16:08:08",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：实控人之一吴美容质押展期943.95万股",
    "href": "http://stock.jrj.com.cn/2020/12/29162231595725.shtml",
    "datetime": "2020-12-29 16:22:41",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司技术中心被认定为国家企业技术中心",
    "href": "http://stock.jrj.com.cn/2020/12/28163831586709.shtml",
    "datetime": "2020-12-28 16:38:53",
    "code": "300723"
  },
  {
    "title": "一品红：第四季度以来累计获得政府补助合计5494.24万元",
    "href": "http://stock.jrj.com.cn/2020/12/28143631586142.shtml",
    "datetime": "2020-12-28 14:36:57",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：子公司近期累计获得政府补助5494.24万元",
    "href": "http://stock.jrj.com.cn/2020/12/28131131585708.shtml",
    "datetime": "2020-12-28 13:11:15",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：可转债发行申请获证监会同意注册批复",
    "href": "http://stock.jrj.com.cn/2020/12/08173031441235.shtml",
    "datetime": "2020-12-08 17:30:02",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：募投项目结项 3522.66万元节余募集资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/11/30201631378131.shtml",
    "datetime": "2020-11-30 20:16:31",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)拟继续使用不超1.5亿元闲置募集资金暂补流动资金",
    "href": "http://stock.jrj.com.cn/2020/11/30201531378133.shtml",
    "datetime": "2020-11-30 20:15:02",
    "code": "300723"
  },
  {
    "title": "一品红2020年前三季度净利1.97亿增长17.19% 收到与经营相关的政府补贴增加",
    "href": "http://stock.jrj.com.cn/2020/10/30091431173241.shtml",
    "datetime": "2020-10-30 09:14:23",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：可转债发行申请获深交所审核通过",
    "href": "http://stock.jrj.com.cn/2020/10/29081031155470.shtml",
    "datetime": "2020-10-29 08:10:41",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：发行可转债募资总额由不超5.3亿元调减为不超4.8亿元",
    "href": "http://stock.jrj.com.cn/2020/09/30220930869269.shtml",
    "datetime": "2020-09-30 22:09:16",
    "code": "300723"
  },
  {
    "title": "一品红：年初至今公司及下属子公司累计获得5892.85万元政府补助",
    "href": "http://stock.jrj.com.cn/2020/09/30154130867394.shtml",
    "datetime": "2020-09-30 15:41:33",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)：1-9月累计获得政府补助5892.85万元",
    "href": "http://stock.jrj.com.cn/2020/09/30143530867303.shtml",
    "datetime": "2020-09-30 14:35:43",
    "code": "300723"
  },
  {
    "title": "一品红拟参与投资设立中山金汇产业基金 基金出资总额为5亿元",
    "href": "http://stock.jrj.com.cn/2020/09/23191430819145.shtml",
    "datetime": "2020-09-23 19:14:06",
    "code": "300723"
  },
  {
    "title": "一品红拟参设中山金汇产业基金 有助于推动公司医疗健康领域产业布局",
    "href": "http://stock.jrj.com.cn/2020/09/23174030818610.shtml",
    "datetime": "2020-09-23 17:40:22",
    "code": "300723"
  },
  {
    "title": "一品红(300723.SZ)拟斥5000万元与粤财投资等共设医药产业投资基金",
    "href": "http://stock.jrj.com.cn/2020/09/23161230818079.shtml",
    "datetime": "2020-09-23 16:12:05",
    "code": "300723"
  },
  {
    "title": "一品红2020年上半年净利8045.61万下滑24.98% 自有产品收入同比下降",
    "href": "http://stock.jrj.com.cn/2020/08/30225230624298.shtml",
    "datetime": "2020-08-30 22:52:49",
    "code": "300723"
  },
  {
    "title": "【龙虎榜】一品红8月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/07180430451165.shtml",
    "datetime": "2020-08-07 18:04:32",
    "code": "300723"
  },
  {
    "title": "一品红：广州子公司取得药品注册证书 有助于增强公司在抗感染领域竞争力",
    "href": "http://stock.jrj.com.cn/2020/08/06154030441799.shtml",
    "datetime": "2020-08-06 15:40:55",
    "code": "300723"
  },
  {
    "title": "一品红：子公司收到盐酸克林霉素胶囊药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/08/06143230441366.shtml",
    "datetime": "2020-08-06 14:32:00",
    "code": "300723"
  },
  {
    "title": "一品红子公司盐酸克林霉素胶囊获药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/08/06121430440506.shtml",
    "datetime": "2020-08-06 12:14:33",
    "code": "300723"
  },
  {
    "title": "[互动]一品红：芩香清解口服液、复方香薷水入选部分省份新型冠状病毒肺炎中医药诊疗方案",
    "href": "http://stock.jrj.com.cn/2020/06/16142129937745.shtml",
    "datetime": "2020-06-16 14:21:42",
    "code": "300723"
  },
  {
    "title": "一品红一季度营收增长：抵御住疫情冲击 自主产品结构已经形成",
    "href": "http://stock.jrj.com.cn/2020/04/23135629358143.shtml",
    "datetime": "2020-04-23 13:56:19",
    "code": "300723"
  },
  {
    "title": "一品红2020年一季度预计净利4200万元–4900万元 同比下降0.31%-14.55%",
    "href": "http://stock.jrj.com.cn/2020/04/09194529248748.shtml",
    "datetime": "2020-04-09 19:45:36",
    "code": "300723"
  },
  {
    "title": "一品红：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/09164029246273.shtml",
    "datetime": "2020-04-09 16:40:03",
    "code": "300723"
  },
  {
    "title": "一品红2019年自有产品收入增逾三成",
    "href": "http://stock.jrj.com.cn/2020/02/27222228909283.shtml",
    "datetime": "2020-02-27 22:22:45",
    "code": "300723"
  },
  {
    "title": "一品红2019年盈利1.48亿元下滑29% 计提应收账款坏账准备",
    "href": "http://stock.jrj.com.cn/2020/02/27170828907352.shtml",
    "datetime": "2020-02-27 17:08:12",
    "code": "300723"
  },
  {
    "title": "一品红：产品入选新冠肺炎中医药诊疗方案",
    "href": "http://stock.jrj.com.cn/2020/02/23230028877383.shtml",
    "datetime": "2020-02-23 23:00:55",
    "code": "300723"
  },
  {
    "title": "一品红：产品入选多省新型冠状病毒肺炎中医药诊疗方案",
    "href": "http://stock.jrj.com.cn/2020/02/23172728876844.shtml",
    "datetime": "2020-02-23 17:27:09",
    "code": "300723"
  },
  {
    "title": "一品红：产品入选多省新型冠状病毒肺炎中医药诊疗方案",
    "href": "http://stock.jrj.com.cn/2020/02/23172128876835.shtml",
    "datetime": "2020-02-23 17:21:00",
    "code": "300723"
  },
  {
    "title": "一品红股东柯瑞玉减持1200股 套现约5万元",
    "href": "http://stock.jrj.com.cn/2020/02/03184228757220.shtml",
    "datetime": "2020-02-03 18:42:48",
    "code": "300723"
  },
  {
    "title": "一品红“芩香清解口服液”进入山东卫健委《山东省新型冠状病毒感染的肺炎中医药诊疗方案》",
    "href": "http://stock.jrj.com.cn/2020/02/03172928756840.shtml",
    "datetime": "2020-02-03 17:29:28",
    "code": "300723"
  },
  {
    "title": "一品红捐赠304万元爱心款和物资抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/02120828748236.shtml",
    "datetime": "2020-02-02 12:08:00",
    "code": "300723"
  },
  {
    "title": "一品红：公司及控股股东捐赠304万元爱心款和物资抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/01220328747566.shtml",
    "datetime": "2020-02-01 22:03:00",
    "code": "300723"
  },
  {
    "title": "一品红2019年度预计净利1.25亿元–1.67亿元 同比下降20%-40%",
    "href": "http://stock.jrj.com.cn/2020/01/20211628708063.shtml",
    "datetime": "2020-01-20 21:16:26",
    "code": "300723"
  },
  {
    "title": "一品红已斥资逾6000万元回购1.02%股份",
    "href": "http://stock.jrj.com.cn/2019/11/25120628446738.shtml",
    "datetime": "2019-11-25 12:06:26",
    "code": "300723"
  },
  {
    "title": "一品红2019年前三季度营收11.91亿元 同比增长10%",
    "href": "http://stock.jrj.com.cn/2019/10/22195128284299.shtml",
    "datetime": "2019-10-22 19:51:13",
    "code": "300723"
  },
  {
    "title": "一品红：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/14211028245122.shtml",
    "datetime": "2019-10-14 21:10:00",
    "code": "300723"
  },
  {
    "title": "一品红上半年净利润同比增逾三成",
    "href": "http://stock.jrj.com.cn/2019/08/15210727983358.shtml",
    "datetime": "2019-08-15 21:07:33",
    "code": "300723"
  },
  {
    "title": "一品红上半年净利润同比增长31.58%",
    "href": "http://stock.jrj.com.cn/2019/08/15172227982088.shtml",
    "datetime": "2019-08-15 17:22:48",
    "code": "300723"
  },
  {
    "title": "一品红：上半年净利1.07亿元 同比增长32%",
    "href": "http://stock.jrj.com.cn/2019/08/15171627982009.shtml",
    "datetime": "2019-08-15 17:16:42",
    "code": "300723"
  },
  {
    "title": "一品红：上半年净利1.07亿元 同比增32%",
    "href": "http://stock.jrj.com.cn/2019/08/15160627981658.shtml",
    "datetime": "2019-08-15 16:06:00",
    "code": "300723"
  },
  {
    "title": "一品红2019年上半年盈利1.1亿 大力推进产品研发和技术创新",
    "href": "http://stock.jrj.com.cn/2019/08/15155927981676.shtml",
    "datetime": "2019-08-15 15:59:54",
    "code": "300723"
  },
  {
    "title": "一品红2019年上半年盈利1.06亿元–1.14亿元 同比上升30%-40%",
    "href": "http://stock.jrj.com.cn/2019/07/15095227840595.shtml",
    "datetime": "2019-07-15 09:52:37",
    "code": "300723"
  },
  {
    "title": "一品红：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/15081027839761.shtml",
    "datetime": "2019-07-15 08:10:00",
    "code": "300723"
  },
  {
    "title": "一品红实际控制人吴美容质押944万股占公司总股本的5.86%",
    "href": "http://stock.jrj.com.cn/2019/07/01143227778415.shtml",
    "datetime": "2019-07-01 14:32:18",
    "code": "300723"
  },
  {
    "title": "一品红股东李捍雄质押920万股 公司去年净利同比增长33%",
    "href": "http://stock.jrj.com.cn/2019/06/05080527665768.shtml",
    "datetime": "2019-06-05 08:05:38",
    "code": "300723"
  },
  {
    "title": "一品红：拟投资5000万元设立全资子公司一品红生物",
    "href": "http://stock.jrj.com.cn/2019/05/29172227638025.shtml",
    "datetime": "2019-05-29 17:22:13",
    "code": "300723"
  },
  {
    "title": "一品红将花不超1.2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2019/05/21230227603467.shtml",
    "datetime": "2019-05-21 23:02:14",
    "code": "300723"
  },
  {
    "title": "净利润增长33% 一品红拟回购6000万到1.2亿元股份",
    "href": "http://stock.jrj.com.cn/2019/05/10115827553201.shtml",
    "datetime": "2019-05-10 11:58:26",
    "code": "300723"
  },
  {
    "title": "一品红：拟斥资0.6亿-1.2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/05/09214127549673.shtml",
    "datetime": "2019-05-09 21:41:06",
    "code": "300723"
  },
  {
    "title": "一品红拟0.6亿元-1.2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/05/09214027549672.shtml",
    "datetime": "2019-05-09 21:40:23",
    "code": "300723"
  },
  {
    "title": "一品红：拟0.6亿元-1.2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/05/09213727549669.shtml",
    "datetime": "2019-05-09 21:37:00",
    "code": "300723"
  },
  {
    "title": "一品红2019年第一季度营收减少9% 净利4915万元 董事长李捍雄上年末持股920万股",
    "href": "http://stock.jrj.com.cn/2019/04/18080027421522.shtml",
    "datetime": "2019-04-18 08:00:23",
    "code": "300723"
  },
  {
    "title": "一品红：一季度净利4915万元 同比增27%",
    "href": "http://stock.jrj.com.cn/2019/04/17163927416411.shtml",
    "datetime": "2019-04-17 16:39:00",
    "code": "300723"
  },
  {
    "title": "深耕儿童药领域一品红年报业绩大增长",
    "href": "http://stock.jrj.com.cn/2019/03/23093627212338.shtml",
    "datetime": "2019-03-23 09:36:04",
    "code": "300723"
  },
  {
    "title": "一品红去年营收14.30亿同比增4% 董事长李捍雄年薪72万元",
    "href": "http://stock.jrj.com.cn/2019/03/13072527158027.shtml",
    "datetime": "2019-03-13 07:25:36",
    "code": "300723"
  },
  {
    "title": "一品红：2018年净利同比增33% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2019/03/12182327155101.shtml",
    "datetime": "2019-03-12 18:23:06",
    "code": "300723"
  },
  {
    "title": "一品红：一季度净利预增10%—30%",
    "href": "http://stock.jrj.com.cn/2019/03/12182027155095.shtml",
    "datetime": "2019-03-12 18:20:42",
    "code": "300723"
  },
  {
    "title": "一品红：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/14131026900971.shtml",
    "datetime": "2019-01-14 13:10:00",
    "code": "300723"
  },
  {
    "title": "午间公告集锦：一品红2018年业绩预增",
    "href": "http://stock.jrj.com.cn/2019/01/14120826900761.shtml",
    "datetime": "2019-01-14 12:08:23",
    "code": "300723"
  },
  {
    "title": "一品红：药品带量采购不会影响公司既定发展目标",
    "href": "http://stock.jrj.com.cn/2018/12/07122525470709.shtml",
    "datetime": "2018-12-07 12:25:00",
    "code": "300723"
  },
  {
    "title": "一品红：首次公开发行前已发行股份上市流通提示性公告",
    "href": "http://stock.jrj.com.cn/2018/11/13210025340781.shtml",
    "datetime": "2018-11-13 21:00:00",
    "code": "300723"
  },
  {
    "title": "一品红：子公司获批设立国家级博士后科研工作站",
    "href": "http://stock.jrj.com.cn/2018/11/12164025333850.shtml",
    "datetime": "2018-11-12 16:40:00",
    "code": "300723"
  },
  {
    "title": "一品红：子公司项目入选广州市新兴产业发展补助计划",
    "href": "http://stock.jrj.com.cn/2018/11/01210925294389.shtml",
    "datetime": "2018-11-01 21:09:00",
    "code": "300723"
  },
  {
    "title": "午间公告集锦：一品红将牵手晟德大药厂引进儿童药",
    "href": "http://stock.jrj.com.cn/2018/10/30121625279036.shtml",
    "datetime": "2018-10-30 12:16:58",
    "code": "300723"
  },
  {
    "title": "一品红：营收最大单品进入国家2018年版基本药物目录",
    "href": "http://stock.jrj.com.cn/2018/10/25213125260455.shtml",
    "datetime": "2018-10-25 21:31:00",
    "code": "300723"
  },
  {
    "title": "一品红三季报扣非净利增24% 业务结构调整提升毛利率",
    "href": "http://stock.jrj.com.cn/2018/10/24193425255127.shtml",
    "datetime": "2018-10-24 19:34:00",
    "code": "300723"
  },
  {
    "title": "一品红：前三季度业绩增长16.6% 三季度单季增长32%",
    "href": "http://stock.jrj.com.cn/2018/10/24183525254968.shtml",
    "datetime": "2018-10-24 18:35:00",
    "code": "300723"
  },
  {
    "title": "一品红三季度净利预增10%-20% 子公司获3818万元政府补助",
    "href": "http://stock.jrj.com.cn/2018/10/09181525177886.shtml",
    "datetime": "2018-10-09 18:15:00",
    "code": "300723"
  },
  {
    "title": "一品红：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/09173025177718.shtml",
    "datetime": "2018-10-09 17:30:00",
    "code": "300723"
  },
  {
    "title": "一品红前三季度净利润预增10%-20%",
    "href": "http://stock.jrj.com.cn/2018/10/09164125177526.shtml",
    "datetime": "2018-10-09 16:41:42",
    "code": "300723"
  },
  {
    "title": "一品红：前三季度净利同比预增10%-20%",
    "href": "http://stock.jrj.com.cn/2018/10/09162025177393.shtml",
    "datetime": "2018-10-09 16:20:00",
    "code": "300723"
  },
  {
    "title": "一品红：已有58个产品在国家医保目录",
    "href": "http://stock.jrj.com.cn/2018/09/05132025050083.shtml",
    "datetime": "2018-09-05 13:20:00",
    "code": "300723"
  },
  {
    "title": "一品红上半年扣非净利增长23% 产品与研发双发力",
    "href": "http://stock.jrj.com.cn/2018/08/23132024991025.shtml",
    "datetime": "2018-08-23 13:20:00",
    "code": "300723"
  },
  {
    "title": "一品红上半年扣非净利预增20%-30%",
    "href": "http://stock.jrj.com.cn/2018/07/13151024813015.shtml",
    "datetime": "2018-07-13 15:10:00",
    "code": "300723"
  },
  {
    "title": "一品红：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/13132024812557.shtml",
    "datetime": "2018-07-13 13:20:00",
    "code": "300723"
  },
  {
    "title": "一品红：前5个月累计收到762万元政府补助",
    "href": "http://stock.jrj.com.cn/2018/06/14202524682652.shtml",
    "datetime": "2018-06-14 20:25:00",
    "code": "300723"
  },
  {
    "title": "一品红子公司收购桃花岛药业股权",
    "href": "http://stock.jrj.com.cn/2018/06/12160924669442.shtml",
    "datetime": "2018-06-12 16:09:12",
    "code": "300723"
  },
  {
    "title": "一品红：取得3项药品发明专利",
    "href": "http://stock.jrj.com.cn/2018/06/05202024640784.shtml",
    "datetime": "2018-06-05 20:20:00",
    "code": "300723"
  },
  {
    "title": "一品红：子公司被认定为首批“广州市创新标杆企业”",
    "href": "http://stock.jrj.com.cn/2018/06/04214524635782.shtml",
    "datetime": "2018-06-04 21:45:00",
    "code": "300723"
  },
  {
    "title": "一品红：今年主要任务是大力开展市场销售工作",
    "href": "http://stock.jrj.com.cn/2018/06/01112524625326.shtml",
    "datetime": "2018-06-01 11:25:00",
    "code": "300723"
  },
  {
    "title": "【e公司微访谈直播】一品红董事长李捍雄：打造儿童药领域的领先企业",
    "href": "http://stock.jrj.com.cn/2018/06/01101524624759.shtml",
    "datetime": "2018-06-01 10:15:00",
    "code": "300723"
  },
  {
    "title": "机构龙虎榜:消费股获关注 1机构买顺鑫农业6960万",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/29212224607250.shtml",
    "datetime": "2018-05-29 21:22:05",
    "code": "300723"
  },
  {
    "title": "一品红：全资子公司获新版GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/21080024565891.shtml",
    "datetime": "2018-05-21 08:00:00",
    "code": "300723"
  },
  {
    "title": "一品红年报推10派1.5元 股权登记5月24日",
    "href": "http://stock.jrj.com.cn/2018/05/18175124560516.shtml",
    "datetime": "2018-05-18 17:51:23",
    "code": "300723"
  },
  {
    "title": "一品红：全资子公司获新版GMP证书",
    "href": "http://stock.jrj.com.cn/2018/05/18174024560414.shtml",
    "datetime": "2018-05-18 17:40:00",
    "code": "300723"
  },
  {
    "title": "一品红2017年业绩增逾一成",
    "href": "http://stock.jrj.com.cn/2018/04/23225824436466.shtml",
    "datetime": "2018-04-23 22:58:26",
    "code": "300723"
  },
  {
    "title": "一品红2017年净利增长14% 产学研联合体夯成长基石",
    "href": "http://stock.jrj.com.cn/2018/04/23211824436066.shtml",
    "datetime": "2018-04-23 21:18:00",
    "code": "300723"
  },
  {
    "title": "一品红：首次跨国投资 拟美国设子公司",
    "href": "http://stock.jrj.com.cn/2018/04/15192024391428.shtml",
    "datetime": "2018-04-15 19:20:00",
    "code": "300723"
  },
  {
    "title": "一品红500万美元在美国设立全资子公司",
    "href": "http://stock.jrj.com.cn/2018/04/15173824391260.shtml",
    "datetime": "2018-04-15 17:38:00",
    "code": "300723"
  },
  {
    "title": "一品红一季度预增25%-35% 股权激励彰显业务信心",
    "href": "http://stock.jrj.com.cn/2018/04/09181524363591.shtml",
    "datetime": "2018-04-09 18:15:00",
    "code": "300723"
  },
  {
    "title": "一品红：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/09134024361960.shtml",
    "datetime": "2018-04-09 13:40:00",
    "code": "300723"
  },
  {
    "title": "一品红公布第一期限制性股票激励计划（草案）",
    "href": "http://stock.jrj.com.cn/2018/04/09082824360195.shtml",
    "datetime": "2018-04-09 08:28:00",
    "code": "300723"
  },
  {
    "title": "机构龙虎榜:高送转预期股获关注 机构买一品红2877万",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/04210324353026.shtml",
    "datetime": "2018-04-04 21:03:59",
    "code": "300723"
  },
  {
    "title": "一品红子公司2亿元竞得广州南沙区地块",
    "href": "http://stock.jrj.com.cn/2018/03/12190624228646.shtml",
    "datetime": "2018-03-12 19:06:45",
    "code": "300723"
  },
  {
    "title": "一品红：子公司产品进入北京市医保目录",
    "href": "http://stock.jrj.com.cn/2018/03/02155524181433.shtml",
    "datetime": "2018-03-02 15:55:00",
    "code": "300723"
  },
  {
    "title": "一品红上市后首份年报预喜 儿童药龙头地位初现",
    "href": "http://stock.jrj.com.cn/2018/01/22192523987015.shtml",
    "datetime": "2018-01-22 19:25:00",
    "code": "300723"
  },
  {
    "title": "一品红2017年度业绩预增20%-35%",
    "href": "http://stock.jrj.com.cn/2018/01/22115723984228.shtml",
    "datetime": "2018-01-22 11:57:00",
    "code": "300723"
  },
  {
    "title": "次新股板块表现萎靡 一品红等多股触及跌停",
    "href": "http://stock.jrj.com.cn/2017/12/04095523735146.shtml",
    "datetime": "2017-12-04 09:55:08",
    "code": "300723"
  },
  {
    "title": "新股提示：一品红开板",
    "href": "http://stock.jrj.com.cn/2017/11/27102523699520.shtml",
    "datetime": "2017-11-27 10:25:00",
    "code": "300723"
  },
  {
    "title": "证监会：一品红药业尚有相关事项需落实 6月7日取消审核",
    "href": "http://stock.jrj.com.cn/2017/06/06193022579211.shtml",
    "datetime": "2017-06-06 19:30:11",
    "code": "300723"
  }
]